First Ebola large-scale vaccine trial starts in Liberia

The first large-scale trial of an experimental Ebola vaccine has started in Liberia.

The first volunteers received the vaccinations, produced by the pharmaceutical companies GSK and Merck.

It is hoped 30,000 people will take part in the trial.

Mark Doyle reports from Monrovia.